UNSPSC 51241244: Etretinate

This classification denotes a retinoic acid agent with the molecular formula C23H30O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 65M2UDR9AG, chemically known as ethyl 9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoate but generally known as etretinate, which bears US NIH Compound Identifier 3312. European Medicines Agency schedules Etretinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07346MIG.

UNSPSC 51241244 Etretinate (Commodity) covers pharmaceutical products, but recent state and local procurement activity under this code shows minimal relevant volume. The single recent opportunity posted—City of Tampa Fire Rescue Department ITB 25-P-00157 for medical aid supplies—solicits a broad category of first aid and emergency medical items including antiseptic sprays, hydrogen peroxide, aspirin, pain relievers, bandages, first aid kits, and emergency blankets, with a total department budget of $100,000 and estimated annual quantities ranging from 1 to 2,700 units per item. This opportunity does not target etretinate specifically and appears to be misclassified under the code; the actual procurement spans general first aid consumables rather than the specialized retinoid pharmaceutical this Commodity code nominally describes.

The City of Tampa Fire Rescue Department issued the only recent opportunity in the source. The ITB 25-P-00157, posted April 24, 2026 with a bid opening date of April 9, 2025, includes set-aside provisions for City-certified Small Local Business Enterprises (SLBEs) and Underutilized Woman and Minority Owned Business Enterprises (U-WMBEs), offering a 5% bid discount on the total bid amount (not to exceed $10,000 for SLBEs and $20,000 for U-WMBEs). All medications must have a minimum nine-month expiration date from the date of acceptance, and the City reserves the right to award the contract by aggregate total or individual line items. The procurement anticipates an initial one-year award period with potential for two additional one-year renewals. This code shows little relevant recent activity for etretinate-specific sourcing in state and local markets.